Viridian Therapeutics, Inc. (LON:0K1R)
London · Delayed Price · Currency is GBP · Price in USD 18.70
+1.54 (9.00%)
At close: Aug 13, 2025
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of 1.13 billion as of August 14, 2025. Its market cap has increased by 37.15% in one year.
Market Cap
1.13B
Enterprise Value
875.44M
Revenue
222.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
18.70
Market Cap Chart
Since February 14, 2017, Viridian Therapeutics's market cap has increased from 138.06M to 1.13B, an increase of 721.66%. That is a compound annual growth rate of 28.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 1.09B | -10.48% |
| Dec 31, 2024 | 1.21B | 34.90% |
| Dec 29, 2023 | 899.17M | -7.85% |
| Dec 30, 2022 | 975.73M | 207.65% |
| Dec 31, 2021 | 317.16M | 573.54% |
| Dec 31, 2020 | 47.09M | 308.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.91B |
| GSK plc | 56.34B |
| Haleon | 31.86B |
| Smith & Nephew | 11.76B |
| ConvaTec Group | 4.64B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 1.92B |